
Cobionix confirmed its robotic arm for healthcare use circumstances on the 2024 Robotics Summit & Expo. Supply: The Robotic Report
Cobionix, which is growing autonomous techniques for the healthcare trade, at present mentioned it has closed a $3 million (U.S.) strategic funding spherical. The corporate mentioned it’s going to use the funding to commercialize CODI, its multi-functional robotic platform designed to boost healthcare supply by superior automation and synthetic intelligence.
As a part of closing the funding, Cobionix not too long ago moved its headquarters to help the required progress for commercialization and manufacturing, sustaining its base in Kitchener, Ontario. The firm began as a member of the MassRobotics Healthcare Catalyst program.
CODI coming to the U.Okay., Canada, and the U.S.
Cobionix described CODI as a “configurable, medical-collaborative robotics platform able to performing a variety of patient-facing duties, together with diagnostic ultrasound procedures.” Not like robots that require vital {hardware} modifications for various medical purposes, CODI’s design permits for speedy adaptation to varied duties by easy device modifications and over-the-air software program updates, asserted the corporate.
CODI is already able to teleoperated ultrasound operation, Dan Vu, director of enterprise improvement at Cobionix, advised The Robotic Report. Nevertheless, the corporate is busy perfecting its absolutely autonomous ultrasound performance, which is the first purpose for the way forward for CODI.
With CODI, it will likely be potential to allow healthcare purposes equivalent to ultrasound appointments for pregnant moms who reside in rural areas with out close by entry to ultrasound services, he mentioned.
Cobionix plans to introduce CODI within the U.Okay. market by the tip of the yr, adopted by Canada in 2026 and the U.S. by mid-2026. The firm selected the U.Okay. because the preliminary launch market due to its supportive atmosphere for innovation and streamlined pathways for ultrasound purposes, in addition to sturdy demand to deal with challenges in ultrasound imaging, in accordance with Vu.
“With an growing want for extremely expert medical care in our nation, particularly in our rural communities, we have to leverage distinctive technological advances to stretch our extremely expert workforce,” mentioned Dr. Ashok Rai, president and CEO of Inexperienced Bay, Wis.-based Prevea Well being.
“CODI does simply that, by permitting ultrasound technologists to carry out ultrasounds remotely with the identical stage of experience and hands-on care as if the affected person was proper in entrance of them,” he added. “Not will the place you reside be a limiting issue within the type of medical care you obtain, due to the expertise that CODI brings to the market.”
TitletownTech backs Cobionix
TitletownTech, a enterprise capital agency backed by Microsoft and the Inexperienced Bay Packers, led Cobionix’s funding spherical. Lions Funding and Dr. Paul McBeth, a medical robotics key opinion chief (KOL), additionally participated, amongst others.
“This partnership with TitletownTech marks a big milestone in our mission to revolutionize healthcare supply and drive the development of human and machine on the affected person’s bedside,” mentioned Matthew Sefati, CEO of Cobionix.
TitletownTech focuses on early-stage startups with vital progress potential in key industries which are reflective of its community and area, particularly these in Wisconsin and the Midwest. The agency has a portfolio of virtually 40 startups, and Cobionix is one in every of its first robotics investments.
“Medical robotics is on the intersection of a number of highly effective expertise traits, and Cobionix is harnessing that convergence in a method that has actual potential to remodel healthcare,” mentioned TitletownTech Managing Accomplice Jill Enos. “We’re excited to help the crew’s imaginative and prescient as the corporate pushes the boundaries of what’s potential on this house.”
“Their help will allow us to increase the attain of CODI, bringing cutting-edge robotic options to healthcare suppliers and sufferers worldwide,” mentioned Nima Zamani, co-founder and chief expertise officer of Cobionix.
The corporate mentioned the funding will assist scale ongoing pilot packages, that are presently within the analysis and medical pilot section, together with partnerships with the Saskatchewan Well being Authority in Canada and the U.Okay. Nationwide Well being Service. The brand new funding will assist help these pilot tasks and “transfer CODI from bench to bedside,” mentioned Cobionix, with a deal with launching within the U.S. market.
